COD lijekovi od interesa
Kodna lista COD lijekovi od interesa.
Specifikacija profila
| CodeSystem |
| id : cod-lijekovi-od-interesa |
| meta |
| versionId : 4 |
| lastUpdated : 2023-06-02T14:18:28.082+00:00 |
| source : #q9xFVv7XBuZZ3D8K |
| text |
| status : generated |
| url : http://fhir.cezih.hr/specifikacije/CodeSystem/cod-lijekovi-od-interesa |
| identifier |
| use : official |
| system : urn:ietf:rfc:3986 |
| value : urn:oid:2.16.840.1.113883.2.7.60.1.155 |
| version : 0.2.4 |
| name : HRCODLijekoviOdInteresa |
| title : COD lijekovi od interesa |
| status : active |
| experimental : False |
| date : 2010-01-01 |
| publisher : Ericsson Nikola Tesla d.d. |
| jurisdiction |
| coding |
| system : urn:iso:std:iso:3166 |
| code : HR |
| display : Croatia |
| text : Croatia |
| caseSensitive : False |
| compositional : False |
| versionNeeded : False |
| content : complete |
| concept |
| code : 1 |
| display : 5-Fluorouracil |
| concept |
| code : 2 |
| display : abemaciklib |
| concept |
| code : 3 |
| display : afatinib |
| concept |
| code : 4 |
| display : aflibercept |
| concept |
| code : 5 |
| display : alektinibklorida |
| concept |
| code : 6 |
| display : alpelisib |
| concept |
| code : 7 |
| display : amivantamab |
| concept |
| code : 8 |
| display : anastrozol |
| concept |
| code : 9 |
| display : atezolizumab |
| concept |
| code : 10 |
| display : bevacizumab |
| concept |
| code : 11 |
| display : brigatinib |
| concept |
| code : 12 |
| display : cemiplimab |
| concept |
| code : 13 |
| display : ceritinib |
| concept |
| code : 14 |
| display : cetuksimab |
| concept |
| code : 15 |
| display : cisplatin |
| concept |
| code : 16 |
| display : dabrafenib |
| concept |
| code : 17 |
| display : dakomitinib hidrat |
| concept |
| code : 18 |
| display : docetaksel |
| concept |
| code : 19 |
| display : doksorubicin |
| concept |
| code : 20 |
| display : durvalumab |
| concept |
| code : 21 |
| display : eksemestan |
| concept |
| code : 22 |
| display : enkorafenib |
| concept |
| code : 23 |
| display : entrektinib |
| concept |
| code : 24 |
| display : epirubicin |
| concept |
| code : 25 |
| display : eribulinmesilat |
| concept |
| code : 26 |
| display : erlotinib |
| concept |
| code : 27 |
| display : etopozid |
| concept |
| code : 28 |
| display : everolimus |
| concept |
| code : 29 |
| display : fulvestrant |
| concept |
| code : 30 |
| display : gefitinib |
| concept |
| code : 31 |
| display : gemcitabin |
| concept |
| code : 32 |
| display : ipilimumab |
| concept |
| code : 33 |
| display : irinotekan |
| concept |
| code : 34 |
| display : kapecitabin |
| concept |
| code : 35 |
| display : kapmatinibdiklorid hidrat |
| concept |
| code : 36 |
| display : karboplatin |
| concept |
| code : 37 |
| display : krizotinib |
| concept |
| code : 38 |
| display : lapatinib |
| concept |
| code : 39 |
| display : larotrektinibsulfat |
| concept |
| code : 40 |
| display : letrozol |
| concept |
| code : 41 |
| display : lorlatinib |
| concept |
| code : 42 |
| display : neratinibmaleat |
| concept |
| code : 43 |
| display : nivolumab |
| concept |
| code : 44 |
| display : oksaliplatin |
| concept |
| code : 45 |
| display : olaparib |
| concept |
| code : 46 |
| display : osimertinib |
| concept |
| code : 47 |
| display : paklitaksel |
| concept |
| code : 48 |
| display : palbociklib |
| concept |
| code : 49 |
| display : panitumumab |
| concept |
| code : 50 |
| display : pembrolizumab |
| concept |
| code : 51 |
| display : pemetreksed |
| concept |
| code : 52 |
| display : pertuzumab |
| concept |
| code : 53 |
| display : pertuzumab + trastuzumab |
| concept |
| code : 54 |
| display : pralsetinib |
| concept |
| code : 55 |
| display : ramucirumab |
| concept |
| code : 56 |
| display : regorafenib |
| concept |
| code : 57 |
| display : ribociklib |
| concept |
| code : 58 |
| display : sacituzumab govitekan |
| concept |
| code : 59 |
| display : sotorasib |
| concept |
| code : 60 |
| display : talazoparib |
| concept |
| code : 61 |
| display : tamoksifen |
| concept |
| code : 62 |
| display : tepotinibklorid hidrat |
| concept |
| code : 63 |
| display : toremifencitrat |
| concept |
| code : 64 |
| display : trametinib |
| concept |
| code : 65 |
| display : trastuzumab |
| concept |
| code : 66 |
| display : trastuzumab derukstekan |
| concept |
| code : 67 |
| display : trastuzumab emtanzin |
| concept |
| code : 68 |
| display : trifluridin + tipiracil |
| concept |
| code : 69 |
| display : tukatinib |
| concept |
| code : 70 |
| display : vinorelbin |
</meta>
--- We have skipped the narrative for better readability of the resource ---
</text>
</identifier>
</coding>
</jurisdiction>
</concept>
</concept>
</concept>
</concept>
</concept>
</concept>
</concept>
</concept>
</concept>
</concept>
</concept>
</concept>
</concept>
</concept>
</concept>
</concept>
</concept>
</concept>
</concept>
</concept>
</concept>
</concept>
</concept>
</concept>
</concept>
</concept>
</concept>
</concept>
</concept>
</concept>
</concept>
</concept>
</concept>
</concept>
</concept>
</concept>
</concept>
</concept>
</concept>
</concept>
</concept>
</concept>
</concept>
</concept>
</concept>
</concept>
</concept>
</concept>
</concept>
</concept>
</concept>
</concept>
</concept>
</concept>
</concept>
</concept>
</concept>
</concept>
</concept>
</concept>
</concept>
</concept>
</concept>
</concept>
</concept>
</concept>
</concept>
</concept>
</concept>
</concept>
</CodeSystem>
{
},
--- We have skipped the narrative for better readability of the resource ---
},
{
}
],
{
],
}
],
{
},
{
},
{
},
{
},
{
},
{
},
{
},
{
},
{
},
{
},
{
},
{
},
{
},
{
},
{
},
{
},
{
},
{
},
{
},
{
},
{
},
{
},
{
},
{
},
{
},
{
},
{
},
{
},
{
},
{
},
{
},
{
},
{
},
{
},
{
},
{
},
{
},
{
},
{
},
{
},
{
},
{
},
{
},
{
},
{
},
{
},
{
},
{
},
{
},
{
},
{
},
{
},
{
},
{
},
{
},
{
},
{
},
{
},
{
},
{
},
{
},
{
},
{
},
{
},
{
},
{
},
{
},
{
},
{
},
{
}
]
}